This content is machine translated TRK Inhibitors Entity-independent cancer therapy: a glimpse of the future? Since 2020, two TRK inhibitors have been approved in Switzerland for tumor diagnosis, i.e. independent of tumor entity. They are designed to treat any solid tumor with NTRK gene fusions,…
